The aim of the study was to evaluate the effect of @entity1289 inhibition on blood pressure and plasma @entity916 activity (PRA) in @entity1 with essential (EH) and renovascular (RVH) @entity101 . Forty @entity1 with RVH and sixty four with EH were studied. All @entity1 underwent renal digital subtraction angiography in order to find out @entity2791 . Blood pressure was measured before and 15, 30, 45, 60 and 90 minutes after @entity3371 administration in the @entity3371 test. PRA was determined before and 60 minutes after @entity3371 . It was shown that fall of systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressure after @entity3371 was significant in each time period both in EH and RVH. @entity551 effect was significantly higher (p < 0.001) in RVH. Basic PRA did not differ in the studied groups. 60 minutes after @entity3371 administration PRA was significantly higher (p < 0.001) in @entity1 with RVH. Absolute and percentage rise of PRA also differentiated studied groups (p < 0.001). Significant correlations were found between the change of PRA after @entity3371 and fall of SAP, DAP and MAP in both groups. These relationships were stronger in RVH.

[Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of XXXX inhibition on blood pressure and plasma @entity916 activity in @entity1 with primary @entity101 and renovascular hypertension].

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1289 :: ('1636', 'Gene') :: ['angiotensin converting enzyme'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity3371 :: ('CHEBI:3380', 'Chemical') :: ['captopril'] @entity2791 :: ('MESH:D012078', 'Disease') :: ['renal artery stenosis'] @entity916 :: ('5972', 'Gene') :: ['renin'] @entity551 :: ('MESH:D007022', 'Disease') :: ['Hypotensive']
@entity1289 :: (1636,Gene) :: ['angiotensin converting enzyme']
